Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat-Reference-Cited by-同舟云学术

Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat

Published:2019-01 Issue: Volume:109 Page:658-670
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yang Chih-Chao,Chen Yen-Ta,Wallace Christopher Glenn,Chen Kuan-Hung,Cheng Ben-Chung,Sung Pei-Hsun,Li Yi-Chen,Ko Sheung-Fat,Chang Hsueh-Wen,Yip Hon-Kan

Funder

Chang Gung University

Chang Gung Memorial Hospital

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference41 articles.

1. Cardiorenal syndrome: review of our current understanding;Hadjiphilippou;J. R. Soc. Med.,2016

2. The cardiorenal syndrome;Ronco;Blood Purif.,2009

3. Low response of renin-angiotensin system to sodium intake intervention in chinese hypertensive patients;Feng;Medicine (Baltimore),2016

4. Cardiorenal syndrome type 1;Ronco;J. Am. Coll. Cardiol.,2012

5. Kidney response to heart failure: proteomic analysis of cardiorenal syndrome;Melenovsky;Kidney Blood Press. Res.,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11

2. SGLT2 inhibitor downregulated oxidative stress via activating AMPK pathway for cardiorenal (CR) protection in CR syndrome rodent fed with high protein diet;Journal of Molecular Histology;2024-08-27

3. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review;Biomedicine & Pharmacotherapy;2024-06

4. Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet;Biomedicine & Pharmacotherapy;2024-05

5. The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors;JACC: CardioOncology;2024-04